As one of the world's leaders in both clinical and basic research, the Huntington's Disease Center at Johns Hopkins offers a wide range of opportunities for individuals and their families to participate in clinical research studies of Huntington's disease (HD). Participants may receive clinical testing and other services related to these studies. Teva Pharmaceutical Industries, Inc., the National Institute of Health (NIH), the Huntington's Disease Society of America (HDSA), and the CHDI Foundation provide major funding support for the Center's on-site research programs.

• Basic Research - laboratories looking for a cure for HD
• Clinical Trials - currently enrolling - testing experimental treatments for HD (closed clinical trials)
• Genetic Studies - looking for factors that influence disease progression

For research information, please contact:

Kia Ultz
Research Program Mananger
410- 955-1349
kcarte23@jhmi.edu

or

Mollie W. Jenckes, MHSc, BSN
Study Coordinator 
410-502-0158
mjenckes@jhmi.edu

or

Etta Goldman
Research Program Coordinator
410-614-7671
egoldm17@jhmi.edu

Johns Hopkins University
600 N. Wolfe Street, Meyer 2-181
Baltimore, MD 21287

410- 955-8233 fax